Lexaria Bioscience (LEXX) Files for 4.55M Share Offering

Lexaria Bioscience (NASDAQ: LEXX) has filed the following:

This prospectus relates to the resale from time to time by the selling stockholder identified herein of up to 4,551,019 shares of common stock, $0.001 par value (“Common Stock”), underlying those certain private placement warrants (the “Common Warrants”). We refer to the 4,551,019 shares of Common Stock underlying the Common Warrants being registered herein as the “Registered Securities.”

The offering price per share of Common Stock and accompanying warrant was $3.06. The Common Warrants have an exercise price of $3.06 per share and will be exercisable on the date of stockholder approval of the issuance of the Common Warrants and underlying shares of Common Stock (the “Stockholder Approval Date”) and will expire five (5) years following the Stockholder Approval Date.

The selling stockholder may offer, sell or distribute all or a portion of the Registered Securities publicly or through private transactions at prevailing market prices or at negotiated prices. The selling stockholder may retain underwriters, dealers or agents from time to time. See “Plan of Distribution” for more information about how the selling stockholder may sell the Registered Securities.

You May Also Be Interested In